Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
MSAC was delisted on the 17th of February, 2023.
54 hedge funds and large institutions have $101M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 6 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
2% less capital invested
Capital invested by funds: $103M → $101M (-$1.91M)
2% less funds holding
Funds holding: 55 → 54 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$4.86M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.53M |
| 3 |
LSC
Logan Stone Capital
Chicago,
Illinois
|
+$2.02M |
| 4 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$1.63M |
| 5 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
-$7.68M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$2.92M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.12M |
| 4 |
HIH
HRS Investment Holdings
New York
|
-$959K |
| 5 |
CIM
Cowen Investment Management
New York
|
-$730K |
MSAC Hedge Fund Activity: Q1 2022 in Review
54 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q1 2022, worth a combined $101M — down 1.9% from $103M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MSAC and 5 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 11 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $4.86M. The largest seller was Third Point, exiting entirely with an estimated $7.68M sold.
- 54 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q1 2022, down from 55 in Q4 2021.
- Funds reported $101M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q1 2022, down 1.9% quarter-over-quarter.
- 5 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q1 2022 and 6 closed out, a net change of -1 holder.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q1 2022 was Cowen and Company, an estimated $4.86M added.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q1 2022 was Third Point, an estimated $7.68M sold.
Based on aggregated 13F filings for Q1 2022.